Cerebral infarcts in a pediatric patient secondary to phenylpropanolamine, a recalled medication

Journal of Emergency Medicine

Volumn 26, Issue 3, 2004, Pages 305-307

  DeIorio, Nicole M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cerebral infarction; Cerebrovascular accident; Overdose; Pediatrics; Phenylpropanolamine

Indexed keywords

PHENYLPROPANOLAMINE;

ARTICLE; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG BLOOD LEVEL; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; STROKE; TREATMENT OUTCOME;

CEREBRAL INFARCTION; CHILD; DRUG AND NARCOTIC CONTROL; DRUGS, NON-PRESCRIPTION; HEADACHE; HUMANS; HYPERTENSION; KIDNEY; MALE; NASAL DECONGESTANTS; PERITONEAL DIALYSIS; PHENYLPROPANOLAMINE; RESPIRATORY TRACT INFECTIONS; SEIZURES; TREATMENT OUTCOME; VASCULITIS; VISION DISORDERS;

EID: 1542613779     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2003.09.009     Document Type: Article

References (7)

1. Kernan W.N., Viscoli C.M., Brass L.M., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 343:2000;1826-1832.
2. Lake C.R., Gallant S., Masson E., Miller P. Adverse drug effects attributed to phenylpropanolamine a review of 142 case reports. Am J Med. 89:1990;195-208.
3. Mersfelder T. Phenylpropanolamine and stroke the study, the FDA ruling, the implications. Cleve Clin J Med. 68:2001;208-223.
4. Horwitz RI, Brass LM, Kernan WN, et al, preparers. Phenylpropanolamine and risk of hemorrhagic stroke. Final report of The Hemorrhagic Stroke Project; 2000 May 10. Available at: www.fda.gov/ohrms/dockets/ac/00/backgrd/ 3647b1&umbar;tab19/doc. Accessed November 10, 2001.
5. Poisindex [computer program]. Micromedex Healthcare Series. Accessed August 31, 2001.
6. FDA letter to manufacturers of drug products containing phenylpropanolamine (PPA) dated 11/03/2000. Available at: www.fda.gov/cder/drug/ infopage/ppa/ppaltr.htm. Accessed August 14, 2003.
7. Phenylpropanolamine (PPA) Information Page. Available at: www.fda.gov/cder/drug/infopage/ppa/default.htm. Accessed August 14, 2003.